URGN Operating Cash Flow Growth
Urogen Pharma Ltd · Operating Cash Flow Growth
URGN Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-29.06%period ending
URGN TTM Cash from Operations YoY % (160.31% → -29.06%)
Year-over-year change
High-resolution chart · PNG
URGN operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -29.0623% | |
| -54.8139% | |
| -67.873% | |
| -43.1744% | |
| -43.447% | |
| -29.978% | |
| -26.5975% | |
| -13.0045% | |
| -1.5437% | |
| 6.8892% | |
| 11.7847% | |
| -0.1965% | |
| 2.5455% | |
| -8.5548% | |
| -2.0674% | |
| 1.2769% | |
| 6.396% | |
| 16.5537% | |
| 19.827% | |
| 22.2154% | |
| 5.5295% | |
| -10.0701% | |
| -49.0995% | |
| -100.0759% | |
| -88.45% | |
| -94.3695% | |
| -90.2207% | |
| -67.5179% | |
| -146.2718% | |
| -177.4711% | |
| -290.0742% | |
| -439.0367% | |
| -684.8367% | |
| -503.681% | |
| -328.4794% | |
| 191.2046% | |
| 142.6129% | |
| 160.3078% |